Medcorp Limited (TTSE:MED)

Medcorp Statistics

Total Valuation

Medcorp has a market cap or net worth of TTD 360.26 million. The enterprise value is 424.55 million.

Market Cap	360.26M
Enterprise Value	424.55M

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Medcorp has 7.83 million shares outstanding. The number of shares has increased by 4.78% in one year.

Current Share Class	7.83M
Shares Outstanding	7.83M
Shares Change (YoY)	+4.78%
Shares Change (QoQ)	+4.81%
Owned by Insiders (%)	82.96%
Owned by Institutions (%)	n/a
Float	1.33M

Valuation Ratios

The trailing PE ratio is 7.95.

PE Ratio	7.95
Forward PE	n/a
PS Ratio	2.97
PB Ratio	3.57
P/TBV Ratio	3.57
P/FCF Ratio	9.37
P/OCF Ratio	8.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.62, with an EV/FCF ratio of 11.04.

EV / Earnings	9.36
EV / Sales	3.50
EV / EBITDA	9.62
EV / EBIT	16.17
EV / FCF	11.04

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.89.

Current Ratio	3.81
Quick Ratio	3.21
Debt / Equity	0.89
Debt / EBITDA	2.27
Debt / FCF	2.33
Interest Coverage	3.52

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	12.60%
Return on Capital Employed (ROCE)	11.31%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	121.16M
Profits Per Employee	45.35M
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Medcorp has paid 2.69 million in taxes.

Income Tax	2.69M
Effective Tax Rate	5.59%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	46.89
200-Day Moving Average	n/a
Relative Strength Index (RSI)	2.37
Average Volume (20 Days)	11

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medcorp had revenue of TTD 121.16 million and earned 45.35 million in profits. Earnings per share was 5.79.

Revenue	121.16M
Gross Profit	58.19M
Operating Income	21.64M
Pretax Income	48.04M
Net Income	45.35M
EBITDA	28.11M
EBIT	21.64M
Earnings Per Share (EPS)	5.79

Balance Sheet

The company has 25.36 million in cash and 89.65 million in debt, with a net cash position of -64.30 million or -8.21 per share.

Cash & Cash Equivalents	25.36M
Total Debt	89.65M
Net Cash	-64.30M
Net Cash Per Share	-8.21
Equity (Book Value)	101.02M
Book Value Per Share	12.89
Working Capital	39.97M

Cash Flow

In the last 12 months, operating cash flow was 43.72 million and capital expenditures -5.26 million, giving a free cash flow of 38.46 million.

Operating Cash Flow	43.72M
Capital Expenditures	-5.26M
Free Cash Flow	38.46M
FCF Per Share	4.91

Margins

Gross margin is 48.03%, with operating and profit margins of 17.86% and 37.43%.

Gross Margin	48.03%
Operating Margin	17.86%
Pretax Margin	39.65%
Profit Margin	37.43%
EBITDA Margin	23.20%
EBIT Margin	17.86%
FCF Margin	31.74%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 4.35%.

Dividend Per Share	2.00
Dividend Yield	4.35%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	34.56%
Buyback Yield	-4.78%
Shareholder Yield	-0.44%
Earnings Yield	12.59%
FCF Yield	10.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medcorp has an Altman Z-Score of 3.92 and a Piotroski F-Score of 4.

Altman Z-Score	3.92
Piotroski F-Score	4